Attenuation of lipopolysaccharide-induced acute lung injury after (pro)renin receptor blockade

Kenjiro Ishii, Hiroya Takeuchi, Koichi Fukunaga, Yuki Hirano, Koichi Suda, Tomoko Hagiwara, Taku Miyasho, Shingo Yamada, Rieko Nakamura, Tsunehiro Takahashi, Norihito Wada, Hirofumi Kawakubo, Yoshiro Saikawa, Tai Omori, Tomoko Betsuyaku, Atsuhiro Ichihara, Yuukou Kitagawa

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Purpose/Aim: We performed a randomized, prospective animal study to investigate whether inhibiting the renin-angiotensin system with a (pro)renin receptor blocker (PRRB) prevents acute lung injury (ALI) in a rodent model. Materials: We used Thirty-six male Sprague-Dawley rats. We administered lipopolysaccharide (LPS; 2 mg/kg) intratracheally with or without PRRB pretreatment (1 mg/kg/d). Methods: We performed bronchoalveolar lavage (BAL) and lung removal at 4 h after LPS administration and measured levels of inflammatory cytokines, high mobility group box 1 (HMGB-1) protein, and total protein in bronchoalveolar lavage fluid (BALF). Myeloperoxidase (MPO) activity was detected in lung tissue homogenates using a sensitive ELISA. We performed hematoxylin and eosin staining and immunohistochemical staining for nonproteolytically activated prorenin in the left lung. Results: The PRRB decreased leukocyte counts and total protein, tumor necrosis factor (TNF)-α, interleukin (IL)-1β, IL-2, IL-6, and IL-10 levels in the BALF and MPO activity in lung tissue. The PRRB reduced interstitial edema, hemorrhage, and the neutrophil count in the lung tissues. Consistent with the reduction in lung tissue damage, immunohistochemical staining showed that the PRRB decreased the amount of nonproteolytically activated prorenin. Conclusions: The PRRB blocked LPS-induced inflammatory response in the lung and protected against ALI. Therefore, it is a potential therapeutic agent for preventing ALI.

Original languageEnglish
Pages (from-to)199-207
Number of pages9
JournalExperimental Lung Research
Volume41
Issue number4
DOIs
Publication statusPublished - 2015 May 1

Fingerprint

Acute Lung Injury
Renin
Lipopolysaccharides
Lung
Tissue
Bronchoalveolar Lavage Fluid
Staining and Labeling
Peroxidase
HMGB1 Protein
Bronchoalveolar Lavage
Fluids
Hematoxylin
Eosine Yellowish-(YS)
Renin-Angiotensin System
Interleukin-1
Leukocyte Count
Angiotensins
Interleukin-10
Interleukin-2
Sprague Dawley Rats

Keywords

  • (pro)renin receptor blocker
  • Acute lung injury
  • Prorenin
  • Reninangiotensin system

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Molecular Biology
  • Clinical Biochemistry

Cite this

Attenuation of lipopolysaccharide-induced acute lung injury after (pro)renin receptor blockade. / Ishii, Kenjiro; Takeuchi, Hiroya; Fukunaga, Koichi; Hirano, Yuki; Suda, Koichi; Hagiwara, Tomoko; Miyasho, Taku; Yamada, Shingo; Nakamura, Rieko; Takahashi, Tsunehiro; Wada, Norihito; Kawakubo, Hirofumi; Saikawa, Yoshiro; Omori, Tai; Betsuyaku, Tomoko; Ichihara, Atsuhiro; Kitagawa, Yuukou.

In: Experimental Lung Research, Vol. 41, No. 4, 01.05.2015, p. 199-207.

Research output: Contribution to journalArticle

Ishii, K, Takeuchi, H, Fukunaga, K, Hirano, Y, Suda, K, Hagiwara, T, Miyasho, T, Yamada, S, Nakamura, R, Takahashi, T, Wada, N, Kawakubo, H, Saikawa, Y, Omori, T, Betsuyaku, T, Ichihara, A & Kitagawa, Y 2015, 'Attenuation of lipopolysaccharide-induced acute lung injury after (pro)renin receptor blockade', Experimental Lung Research, vol. 41, no. 4, pp. 199-207. https://doi.org/10.3109/01902148.2014.993444
Ishii, Kenjiro ; Takeuchi, Hiroya ; Fukunaga, Koichi ; Hirano, Yuki ; Suda, Koichi ; Hagiwara, Tomoko ; Miyasho, Taku ; Yamada, Shingo ; Nakamura, Rieko ; Takahashi, Tsunehiro ; Wada, Norihito ; Kawakubo, Hirofumi ; Saikawa, Yoshiro ; Omori, Tai ; Betsuyaku, Tomoko ; Ichihara, Atsuhiro ; Kitagawa, Yuukou. / Attenuation of lipopolysaccharide-induced acute lung injury after (pro)renin receptor blockade. In: Experimental Lung Research. 2015 ; Vol. 41, No. 4. pp. 199-207.
@article{9af4d5fddc2e494b872ee3fbb70a99ab,
title = "Attenuation of lipopolysaccharide-induced acute lung injury after (pro)renin receptor blockade",
abstract = "Purpose/Aim: We performed a randomized, prospective animal study to investigate whether inhibiting the renin-angiotensin system with a (pro)renin receptor blocker (PRRB) prevents acute lung injury (ALI) in a rodent model. Materials: We used Thirty-six male Sprague-Dawley rats. We administered lipopolysaccharide (LPS; 2 mg/kg) intratracheally with or without PRRB pretreatment (1 mg/kg/d). Methods: We performed bronchoalveolar lavage (BAL) and lung removal at 4 h after LPS administration and measured levels of inflammatory cytokines, high mobility group box 1 (HMGB-1) protein, and total protein in bronchoalveolar lavage fluid (BALF). Myeloperoxidase (MPO) activity was detected in lung tissue homogenates using a sensitive ELISA. We performed hematoxylin and eosin staining and immunohistochemical staining for nonproteolytically activated prorenin in the left lung. Results: The PRRB decreased leukocyte counts and total protein, tumor necrosis factor (TNF)-α, interleukin (IL)-1β, IL-2, IL-6, and IL-10 levels in the BALF and MPO activity in lung tissue. The PRRB reduced interstitial edema, hemorrhage, and the neutrophil count in the lung tissues. Consistent with the reduction in lung tissue damage, immunohistochemical staining showed that the PRRB decreased the amount of nonproteolytically activated prorenin. Conclusions: The PRRB blocked LPS-induced inflammatory response in the lung and protected against ALI. Therefore, it is a potential therapeutic agent for preventing ALI.",
keywords = "(pro)renin receptor blocker, Acute lung injury, Prorenin, Reninangiotensin system",
author = "Kenjiro Ishii and Hiroya Takeuchi and Koichi Fukunaga and Yuki Hirano and Koichi Suda and Tomoko Hagiwara and Taku Miyasho and Shingo Yamada and Rieko Nakamura and Tsunehiro Takahashi and Norihito Wada and Hirofumi Kawakubo and Yoshiro Saikawa and Tai Omori and Tomoko Betsuyaku and Atsuhiro Ichihara and Yuukou Kitagawa",
year = "2015",
month = "5",
day = "1",
doi = "10.3109/01902148.2014.993444",
language = "English",
volume = "41",
pages = "199--207",
journal = "Experimental Lung Research",
issn = "0190-2148",
publisher = "Informa Healthcare",
number = "4",

}

TY - JOUR

T1 - Attenuation of lipopolysaccharide-induced acute lung injury after (pro)renin receptor blockade

AU - Ishii, Kenjiro

AU - Takeuchi, Hiroya

AU - Fukunaga, Koichi

AU - Hirano, Yuki

AU - Suda, Koichi

AU - Hagiwara, Tomoko

AU - Miyasho, Taku

AU - Yamada, Shingo

AU - Nakamura, Rieko

AU - Takahashi, Tsunehiro

AU - Wada, Norihito

AU - Kawakubo, Hirofumi

AU - Saikawa, Yoshiro

AU - Omori, Tai

AU - Betsuyaku, Tomoko

AU - Ichihara, Atsuhiro

AU - Kitagawa, Yuukou

PY - 2015/5/1

Y1 - 2015/5/1

N2 - Purpose/Aim: We performed a randomized, prospective animal study to investigate whether inhibiting the renin-angiotensin system with a (pro)renin receptor blocker (PRRB) prevents acute lung injury (ALI) in a rodent model. Materials: We used Thirty-six male Sprague-Dawley rats. We administered lipopolysaccharide (LPS; 2 mg/kg) intratracheally with or without PRRB pretreatment (1 mg/kg/d). Methods: We performed bronchoalveolar lavage (BAL) and lung removal at 4 h after LPS administration and measured levels of inflammatory cytokines, high mobility group box 1 (HMGB-1) protein, and total protein in bronchoalveolar lavage fluid (BALF). Myeloperoxidase (MPO) activity was detected in lung tissue homogenates using a sensitive ELISA. We performed hematoxylin and eosin staining and immunohistochemical staining for nonproteolytically activated prorenin in the left lung. Results: The PRRB decreased leukocyte counts and total protein, tumor necrosis factor (TNF)-α, interleukin (IL)-1β, IL-2, IL-6, and IL-10 levels in the BALF and MPO activity in lung tissue. The PRRB reduced interstitial edema, hemorrhage, and the neutrophil count in the lung tissues. Consistent with the reduction in lung tissue damage, immunohistochemical staining showed that the PRRB decreased the amount of nonproteolytically activated prorenin. Conclusions: The PRRB blocked LPS-induced inflammatory response in the lung and protected against ALI. Therefore, it is a potential therapeutic agent for preventing ALI.

AB - Purpose/Aim: We performed a randomized, prospective animal study to investigate whether inhibiting the renin-angiotensin system with a (pro)renin receptor blocker (PRRB) prevents acute lung injury (ALI) in a rodent model. Materials: We used Thirty-six male Sprague-Dawley rats. We administered lipopolysaccharide (LPS; 2 mg/kg) intratracheally with or without PRRB pretreatment (1 mg/kg/d). Methods: We performed bronchoalveolar lavage (BAL) and lung removal at 4 h after LPS administration and measured levels of inflammatory cytokines, high mobility group box 1 (HMGB-1) protein, and total protein in bronchoalveolar lavage fluid (BALF). Myeloperoxidase (MPO) activity was detected in lung tissue homogenates using a sensitive ELISA. We performed hematoxylin and eosin staining and immunohistochemical staining for nonproteolytically activated prorenin in the left lung. Results: The PRRB decreased leukocyte counts and total protein, tumor necrosis factor (TNF)-α, interleukin (IL)-1β, IL-2, IL-6, and IL-10 levels in the BALF and MPO activity in lung tissue. The PRRB reduced interstitial edema, hemorrhage, and the neutrophil count in the lung tissues. Consistent with the reduction in lung tissue damage, immunohistochemical staining showed that the PRRB decreased the amount of nonproteolytically activated prorenin. Conclusions: The PRRB blocked LPS-induced inflammatory response in the lung and protected against ALI. Therefore, it is a potential therapeutic agent for preventing ALI.

KW - (pro)renin receptor blocker

KW - Acute lung injury

KW - Prorenin

KW - Reninangiotensin system

UR - http://www.scopus.com/inward/record.url?scp=84928480404&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84928480404&partnerID=8YFLogxK

U2 - 10.3109/01902148.2014.993444

DO - 10.3109/01902148.2014.993444

M3 - Article

C2 - 25844689

AN - SCOPUS:84928480404

VL - 41

SP - 199

EP - 207

JO - Experimental Lung Research

JF - Experimental Lung Research

SN - 0190-2148

IS - 4

ER -